Long-term use of inhaled corticosteroids and risk of upper respiratory tract infection in chronic obstructive pulmonary disease: a meta-analysis

Efficacy and Safety of a Fixed-Dose Combination of Indacaterol and Glycopyrronium for the Treatment of COPD

(2014) Gustavo J. Rodrigo et al.   CHEST

Use of Inhaled Corticosteroids in Patients With COPD and the Risk of TB and Influenza

(2014) Yaa-Hui Dong et al.   CHEST

Inhaled corticosteroids in COPD: the clinical evidence

(2014) Pierre Ernst et al.   EUROPEAN RESPIRATORY JOURNAL

Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD

(2012) Dennis Doherty et al.   International Journal of Chronic Obstructive Pulmonary Disease

Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study

(2011) Amir Sharafkhaneh et al.   RESPIRATORY MEDICINE

Beclomethasone/formoterol in the management of COPD: A randomised controlled trial

(2010) P.M.A. Calverley et al.   RESPIRATORY MEDICINE

Long-term Use of Inhaled Corticosteroids and the Risk of Pneumonia in Chronic Obstructive Pulmonary Disease

(2009) Sonal Singh et al.   ARCHIVES OF INTERNAL MEDICINE

Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada

(2009) Paul Brassard et al.   ARTHRITIS AND RHEUMATISM

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes

(2009) Antonio Anzueto et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Effect of fluticasone propionate/salmeterol (250/50μg) or salmeterol (50μg) on COPD exacerbations

(2008) Gary T. Ferguson et al.   RESPIRATORY MEDICINE

The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide

(2007) Jadwiga A. Wedzicha et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE